nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—Hypersensitivity—Azathioprine—multiple sclerosis	0.00189	0.00189	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.00189	0.00189	CcSEcCtD
Metolazone—Malaise—Prednisolone—multiple sclerosis	0.00188	0.00188	CcSEcCtD
Metolazone—Dysgeusia—Triamcinolone—multiple sclerosis	0.00188	0.00188	CcSEcCtD
Metolazone—Nausea—Cladribine—multiple sclerosis	0.00187	0.00187	CcSEcCtD
Metolazone—Vertigo—Prednisolone—multiple sclerosis	0.00187	0.00187	CcSEcCtD
Metolazone—Syncope—Prednisolone—multiple sclerosis	0.00187	0.00187	CcSEcCtD
Metolazone—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00186	0.00186	CcSEcCtD
Metolazone—Back pain—Triamcinolone—multiple sclerosis	0.00185	0.00185	CcSEcCtD
Metolazone—Somnolence—Mitoxantrone—multiple sclerosis	0.00184	0.00184	CcSEcCtD
Metolazone—Loss of consciousness—Prednisolone—multiple sclerosis	0.00183	0.00183	CcSEcCtD
Metolazone—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00182	0.00182	CcSEcCtD
Metolazone—Decreased appetite—Mitoxantrone—multiple sclerosis	0.0018	0.0018	CcSEcCtD
Metolazone—Hypertension—Prednisolone—multiple sclerosis	0.0018	0.0018	CcSEcCtD
Metolazone—Fatigue—Mitoxantrone—multiple sclerosis	0.00179	0.00179	CcSEcCtD
Metolazone—Pancreatitis—Methotrexate—multiple sclerosis	0.00178	0.00178	CcSEcCtD
Metolazone—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.00178	0.00178	CcSEcCtD
Metolazone—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.00177	0.00177	CcSEcCtD
Metolazone—Pain—Mitoxantrone—multiple sclerosis	0.00177	0.00177	CcSEcCtD
Metolazone—Constipation—Mitoxantrone—multiple sclerosis	0.00177	0.00177	CcSEcCtD
Metolazone—Diarrhoea—Azathioprine—multiple sclerosis	0.00175	0.00175	CcSEcCtD
Metolazone—Discomfort—Prednisolone—multiple sclerosis	0.00175	0.00175	CcSEcCtD
Metolazone—Abdominal discomfort—Methotrexate—multiple sclerosis	0.00174	0.00174	CcSEcCtD
Metolazone—Malaise—Triamcinolone—multiple sclerosis	0.00173	0.00173	CcSEcCtD
Metolazone—Malaise—Methylprednisolone—multiple sclerosis	0.00172	0.00172	CcSEcCtD
Metolazone—Vertigo—Triamcinolone—multiple sclerosis	0.00172	0.00172	CcSEcCtD
Metolazone—Syncope—Triamcinolone—multiple sclerosis	0.00172	0.00172	CcSEcCtD
Metolazone—Vertigo—Methylprednisolone—multiple sclerosis	0.00172	0.00172	CcSEcCtD
Metolazone—Syncope—Methylprednisolone—multiple sclerosis	0.00171	0.00171	CcSEcCtD
Metolazone—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00171	0.00171	CcSEcCtD
Metolazone—Dizziness—Azathioprine—multiple sclerosis	0.00169	0.00169	CcSEcCtD
Metolazone—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00169	0.00169	CcSEcCtD
Metolazone—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00168	0.00168	CcSEcCtD
Metolazone—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00168	0.00168	CcSEcCtD
Metolazone—Shock—Prednisolone—multiple sclerosis	0.00167	0.00167	CcSEcCtD
Metolazone—Erectile dysfunction—Methotrexate—multiple sclerosis	0.00167	0.00167	CcSEcCtD
Metolazone—Cough—Triamcinolone—multiple sclerosis	0.00167	0.00167	CcSEcCtD
Metolazone—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.00166	0.00166	CcSEcCtD
Metolazone—Hypertension—Triamcinolone—multiple sclerosis	0.00165	0.00165	CcSEcCtD
Metolazone—Hypertension—Methylprednisolone—multiple sclerosis	0.00165	0.00165	CcSEcCtD
Metolazone—Urticaria—Mitoxantrone—multiple sclerosis	0.00165	0.00165	CcSEcCtD
Metolazone—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00164	0.00164	CcSEcCtD
Metolazone—Vomiting—Azathioprine—multiple sclerosis	0.00163	0.00163	CcSEcCtD
Metolazone—Arthralgia—Methylprednisolone—multiple sclerosis	0.00163	0.00163	CcSEcCtD
Metolazone—Anxiety—Methylprednisolone—multiple sclerosis	0.00162	0.00162	CcSEcCtD
Metolazone—Drowsiness—Methotrexate—multiple sclerosis	0.00162	0.00162	CcSEcCtD
Metolazone—Rash—Azathioprine—multiple sclerosis	0.00162	0.00162	CcSEcCtD
Metolazone—Dermatitis—Azathioprine—multiple sclerosis	0.00161	0.00161	CcSEcCtD
Metolazone—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00161	0.00161	CcSEcCtD
Metolazone—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00161	0.00161	CcSEcCtD
Metolazone—Discomfort—Triamcinolone—multiple sclerosis	0.00161	0.00161	CcSEcCtD
Metolazone—Discomfort—Methylprednisolone—multiple sclerosis	0.00161	0.00161	CcSEcCtD
Metolazone—Headache—Azathioprine—multiple sclerosis	0.00161	0.00161	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.0016	0.0016	CcSEcCtD
Metolazone—Dry mouth—Triamcinolone—multiple sclerosis	0.00159	0.00159	CcSEcCtD
Metolazone—Malaise—Dexamethasone—multiple sclerosis	0.00157	0.00157	CcSEcCtD
Metolazone—Malaise—Betamethasone—multiple sclerosis	0.00157	0.00157	CcSEcCtD
Metolazone—Vertigo—Betamethasone—multiple sclerosis	0.00156	0.00156	CcSEcCtD
Metolazone—Vertigo—Dexamethasone—multiple sclerosis	0.00156	0.00156	CcSEcCtD
Metolazone—Syncope—Betamethasone—multiple sclerosis	0.00156	0.00156	CcSEcCtD
Metolazone—Syncope—Dexamethasone—multiple sclerosis	0.00156	0.00156	CcSEcCtD
Metolazone—Shock—Triamcinolone—multiple sclerosis	0.00154	0.00154	CcSEcCtD
Metolazone—Insomnia—Prednisolone—multiple sclerosis	0.00154	0.00154	CcSEcCtD
Metolazone—Shock—Methylprednisolone—multiple sclerosis	0.00153	0.00153	CcSEcCtD
Metolazone—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00153	0.00153	CcSEcCtD
Metolazone—Loss of consciousness—Betamethasone—multiple sclerosis	0.00153	0.00153	CcSEcCtD
Metolazone—Epistaxis—Methotrexate—multiple sclerosis	0.00153	0.00153	CcSEcCtD
Metolazone—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00153	0.00153	CcSEcCtD
Metolazone—Paraesthesia—Prednisolone—multiple sclerosis	0.00153	0.00153	CcSEcCtD
Metolazone—Nausea—Azathioprine—multiple sclerosis	0.00152	0.00152	CcSEcCtD
Metolazone—Agranulocytosis—Methotrexate—multiple sclerosis	0.00151	0.00151	CcSEcCtD
Metolazone—Hypertension—Betamethasone—multiple sclerosis	0.0015	0.0015	CcSEcCtD
Metolazone—Hypertension—Dexamethasone—multiple sclerosis	0.0015	0.0015	CcSEcCtD
Metolazone—Asthenia—Mitoxantrone—multiple sclerosis	0.00149	0.00149	CcSEcCtD
Metolazone—Anxiety—Dexamethasone—multiple sclerosis	0.00147	0.00147	CcSEcCtD
Metolazone—Anxiety—Betamethasone—multiple sclerosis	0.00147	0.00147	CcSEcCtD
Metolazone—Discomfort—Betamethasone—multiple sclerosis	0.00146	0.00146	CcSEcCtD
Metolazone—Discomfort—Dexamethasone—multiple sclerosis	0.00146	0.00146	CcSEcCtD
Metolazone—Pain—Prednisolone—multiple sclerosis	0.00145	0.00145	CcSEcCtD
Metolazone—Hepatitis—Methotrexate—multiple sclerosis	0.00145	0.00145	CcSEcCtD
Metolazone—Vision blurred—Prednisone—multiple sclerosis	0.00143	0.00143	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00142	0.00142	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00142	0.00142	CcSEcCtD
Metolazone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00142	0.00142	CcSEcCtD
Metolazone—Insomnia—Triamcinolone—multiple sclerosis	0.00141	0.00141	CcSEcCtD
Metolazone—Insomnia—Methylprednisolone—multiple sclerosis	0.00141	0.00141	CcSEcCtD
Metolazone—Ill-defined disorder—Prednisone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Metolazone—Paraesthesia—Triamcinolone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Metolazone—Feeling abnormal—Prednisolone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Metolazone—Paraesthesia—Methylprednisolone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Metolazone—Anaemia—Prednisone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Metolazone—Shock—Dexamethasone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Metolazone—Shock—Betamethasone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Metolazone—Agitation—Prednisone—multiple sclerosis	0.00139	0.00139	CcSEcCtD
Metolazone—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00139	0.00139	CcSEcCtD
Metolazone—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00139	0.00139	CcSEcCtD
Metolazone—Dyspepsia—Triamcinolone—multiple sclerosis	0.00138	0.00138	CcSEcCtD
Metolazone—Erythema multiforme—Methotrexate—multiple sclerosis	0.00137	0.00137	CcSEcCtD
Metolazone—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00137	0.00137	CcSEcCtD
Metolazone—Malaise—Prednisone—multiple sclerosis	0.00136	0.00136	CcSEcCtD
Metolazone—Vertigo—Prednisone—multiple sclerosis	0.00136	0.00136	CcSEcCtD
Metolazone—Syncope—Prednisone—multiple sclerosis	0.00136	0.00136	CcSEcCtD
Metolazone—Tinnitus—Methotrexate—multiple sclerosis	0.00135	0.00135	CcSEcCtD
Metolazone—Anorexia—Betamethasone—multiple sclerosis	0.00135	0.00135	CcSEcCtD
Metolazone—Anorexia—Dexamethasone—multiple sclerosis	0.00135	0.00135	CcSEcCtD
Metolazone—Urticaria—Prednisolone—multiple sclerosis	0.00135	0.00135	CcSEcCtD
Metolazone—Fatigue—Triamcinolone—multiple sclerosis	0.00135	0.00135	CcSEcCtD
Metolazone—Fatigue—Methylprednisolone—multiple sclerosis	0.00134	0.00134	CcSEcCtD
Metolazone—Pain—Triamcinolone—multiple sclerosis	0.00134	0.00134	CcSEcCtD
Metolazone—Loss of consciousness—Prednisone—multiple sclerosis	0.00133	0.00133	CcSEcCtD
Metolazone—Vomiting—Mitoxantrone—multiple sclerosis	0.00132	0.00132	CcSEcCtD
Metolazone—Hypertension—Prednisone—multiple sclerosis	0.00131	0.00131	CcSEcCtD
Metolazone—Rash—Mitoxantrone—multiple sclerosis	0.00131	0.00131	CcSEcCtD
Metolazone—Dermatitis—Mitoxantrone—multiple sclerosis	0.00131	0.00131	CcSEcCtD
Metolazone—Chills—Methotrexate—multiple sclerosis	0.0013	0.0013	CcSEcCtD
Metolazone—Headache—Mitoxantrone—multiple sclerosis	0.0013	0.0013	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00129	0.00129	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00129	0.00129	CcSEcCtD
Metolazone—Arthralgia—Prednisone—multiple sclerosis	0.00129	0.00129	CcSEcCtD
Metolazone—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00129	0.00129	CcSEcCtD
Metolazone—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00129	0.00129	CcSEcCtD
Metolazone—Anxiety—Prednisone—multiple sclerosis	0.00128	0.00128	CcSEcCtD
Metolazone—Insomnia—Dexamethasone—multiple sclerosis	0.00128	0.00128	CcSEcCtD
Metolazone—Insomnia—Betamethasone—multiple sclerosis	0.00128	0.00128	CcSEcCtD
Metolazone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00128	0.00128	CcSEcCtD
Metolazone—Paraesthesia—Betamethasone—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Metolazone—Paraesthesia—Dexamethasone—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Metolazone—Discomfort—Prednisone—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Metolazone—Hypersensitivity—Prednisolone—multiple sclerosis	0.00125	0.00125	CcSEcCtD
Metolazone—Dyspepsia—Dexamethasone—multiple sclerosis	0.00125	0.00125	CcSEcCtD
Metolazone—Dyspepsia—Betamethasone—multiple sclerosis	0.00125	0.00125	CcSEcCtD
Metolazone—Urticaria—Triamcinolone—multiple sclerosis	0.00124	0.00124	CcSEcCtD
Metolazone—Urticaria—Methylprednisolone—multiple sclerosis	0.00124	0.00124	CcSEcCtD
Metolazone—Dysgeusia—Methotrexate—multiple sclerosis	0.00124	0.00124	CcSEcCtD
Metolazone—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00123	0.00123	CcSEcCtD
Metolazone—Decreased appetite—Dexamethasone—multiple sclerosis	0.00123	0.00123	CcSEcCtD
Metolazone—Decreased appetite—Betamethasone—multiple sclerosis	0.00123	0.00123	CcSEcCtD
Metolazone—Nausea—Mitoxantrone—multiple sclerosis	0.00123	0.00123	CcSEcCtD
Metolazone—Back pain—Methotrexate—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Metolazone—Fatigue—Dexamethasone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Metolazone—Fatigue—Betamethasone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Metolazone—Shock—Prednisone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Metolazone—Pain—Betamethasone—multiple sclerosis	0.00121	0.00121	CcSEcCtD
Metolazone—Pain—Dexamethasone—multiple sclerosis	0.00121	0.00121	CcSEcCtD
Metolazone—Vision blurred—Methotrexate—multiple sclerosis	0.00119	0.00119	CcSEcCtD
Metolazone—Anorexia—Prednisone—multiple sclerosis	0.00118	0.00118	CcSEcCtD
Metolazone—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00117	0.00117	CcSEcCtD
Metolazone—Anaemia—Methotrexate—multiple sclerosis	0.00117	0.00117	CcSEcCtD
Metolazone—Feeling abnormal—Betamethasone—multiple sclerosis	0.00117	0.00117	CcSEcCtD
Metolazone—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00117	0.00117	CcSEcCtD
Metolazone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00116	0.00116	CcSEcCtD
Metolazone—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00116	0.00116	CcSEcCtD
Metolazone—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00115	0.00115	CcSEcCtD
Metolazone—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00115	0.00115	CcSEcCtD
Metolazone—Malaise—Methotrexate—multiple sclerosis	0.00114	0.00114	CcSEcCtD
Metolazone—Vertigo—Methotrexate—multiple sclerosis	0.00114	0.00114	CcSEcCtD
Metolazone—Leukopenia—Methotrexate—multiple sclerosis	0.00113	0.00113	CcSEcCtD
Metolazone—Urticaria—Dexamethasone—multiple sclerosis	0.00113	0.00113	CcSEcCtD
Metolazone—Urticaria—Betamethasone—multiple sclerosis	0.00113	0.00113	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00113	0.00113	CcSEcCtD
Metolazone—Dizziness—Prednisolone—multiple sclerosis	0.00112	0.00112	CcSEcCtD
Metolazone—Asthenia—Triamcinolone—multiple sclerosis	0.00112	0.00112	CcSEcCtD
Metolazone—Abdominal pain—Dexamethasone—multiple sclerosis	0.00112	0.00112	CcSEcCtD
Metolazone—Abdominal pain—Betamethasone—multiple sclerosis	0.00112	0.00112	CcSEcCtD
Metolazone—Asthenia—Methylprednisolone—multiple sclerosis	0.00112	0.00112	CcSEcCtD
Metolazone—Insomnia—Prednisone—multiple sclerosis	0.00112	0.00112	CcSEcCtD
Metolazone—Paraesthesia—Prednisone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Metolazone—Pruritus—Triamcinolone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Metolazone—Cough—Methotrexate—multiple sclerosis	0.0011	0.0011	CcSEcCtD
Metolazone—Pruritus—Methylprednisolone—multiple sclerosis	0.0011	0.0011	CcSEcCtD
Metolazone—Dyspepsia—Prednisone—multiple sclerosis	0.00109	0.00109	CcSEcCtD
Metolazone—Chest pain—Methotrexate—multiple sclerosis	0.00108	0.00108	CcSEcCtD
Metolazone—Arthralgia—Methotrexate—multiple sclerosis	0.00108	0.00108	CcSEcCtD
Metolazone—Decreased appetite—Prednisone—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Metolazone—Rash—Prednisolone—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Metolazone—Dermatitis—Prednisolone—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Metolazone—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Metolazone—Fatigue—Prednisone—multiple sclerosis	0.00106	0.00106	CcSEcCtD
Metolazone—Headache—Prednisolone—multiple sclerosis	0.00106	0.00106	CcSEcCtD
Metolazone—Discomfort—Methotrexate—multiple sclerosis	0.00106	0.00106	CcSEcCtD
Metolazone—Constipation—Prednisone—multiple sclerosis	0.00106	0.00106	CcSEcCtD
Metolazone—Dizziness—Triamcinolone—multiple sclerosis	0.00103	0.00103	CcSEcCtD
Metolazone—Dizziness—Methylprednisolone—multiple sclerosis	0.00103	0.00103	CcSEcCtD
Metolazone—Feeling abnormal—Prednisone—multiple sclerosis	0.00102	0.00102	CcSEcCtD
Metolazone—Asthenia—Betamethasone—multiple sclerosis	0.00102	0.00102	CcSEcCtD
Metolazone—Asthenia—Dexamethasone—multiple sclerosis	0.00102	0.00102	CcSEcCtD
Metolazone—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00101	0.00101	CcSEcCtD
Metolazone—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00101	0.00101	CcSEcCtD
Metolazone—Nausea—Prednisolone—multiple sclerosis	0.00101	0.00101	CcSEcCtD
Metolazone—Pruritus—Betamethasone—multiple sclerosis	0.001	0.001	CcSEcCtD
Metolazone—Pruritus—Dexamethasone—multiple sclerosis	0.001	0.001	CcSEcCtD
Metolazone—Vomiting—Triamcinolone—multiple sclerosis	0.000994	0.000994	CcSEcCtD
Metolazone—Vomiting—Methylprednisolone—multiple sclerosis	0.000992	0.000992	CcSEcCtD
Metolazone—Rash—Triamcinolone—multiple sclerosis	0.000986	0.000986	CcSEcCtD
Metolazone—Dermatitis—Triamcinolone—multiple sclerosis	0.000985	0.000985	CcSEcCtD
Metolazone—Anorexia—Methotrexate—multiple sclerosis	0.000984	0.000984	CcSEcCtD
Metolazone—Rash—Methylprednisolone—multiple sclerosis	0.000983	0.000983	CcSEcCtD
Metolazone—Dermatitis—Methylprednisolone—multiple sclerosis	0.000982	0.000982	CcSEcCtD
Metolazone—Urticaria—Prednisone—multiple sclerosis	0.000981	0.000981	CcSEcCtD
Metolazone—Headache—Triamcinolone—multiple sclerosis	0.000979	0.000979	CcSEcCtD
Metolazone—Headache—Methylprednisolone—multiple sclerosis	0.000977	0.000977	CcSEcCtD
Metolazone—Abdominal pain—Prednisone—multiple sclerosis	0.000976	0.000976	CcSEcCtD
Metolazone—Diarrhoea—Betamethasone—multiple sclerosis	0.00097	0.00097	CcSEcCtD
Metolazone—Diarrhoea—Dexamethasone—multiple sclerosis	0.00097	0.00097	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00094	0.00094	CcSEcCtD
Metolazone—Dizziness—Dexamethasone—multiple sclerosis	0.000938	0.000938	CcSEcCtD
Metolazone—Dizziness—Betamethasone—multiple sclerosis	0.000938	0.000938	CcSEcCtD
Metolazone—Insomnia—Methotrexate—multiple sclerosis	0.000934	0.000934	CcSEcCtD
Metolazone—Nausea—Triamcinolone—multiple sclerosis	0.000928	0.000928	CcSEcCtD
Metolazone—Paraesthesia—Methotrexate—multiple sclerosis	0.000927	0.000927	CcSEcCtD
Metolazone—Nausea—Methylprednisolone—multiple sclerosis	0.000926	0.000926	CcSEcCtD
Metolazone—Somnolence—Methotrexate—multiple sclerosis	0.000918	0.000918	CcSEcCtD
Metolazone—Hypersensitivity—Prednisone—multiple sclerosis	0.00091	0.00091	CcSEcCtD
Metolazone—Dyspepsia—Methotrexate—multiple sclerosis	0.000909	0.000909	CcSEcCtD
Metolazone—Vomiting—Betamethasone—multiple sclerosis	0.000902	0.000902	CcSEcCtD
Metolazone—Vomiting—Dexamethasone—multiple sclerosis	0.000902	0.000902	CcSEcCtD
Metolazone—Decreased appetite—Methotrexate—multiple sclerosis	0.000897	0.000897	CcSEcCtD
Metolazone—Rash—Dexamethasone—multiple sclerosis	0.000894	0.000894	CcSEcCtD
Metolazone—Rash—Betamethasone—multiple sclerosis	0.000894	0.000894	CcSEcCtD
Metolazone—Dermatitis—Dexamethasone—multiple sclerosis	0.000893	0.000893	CcSEcCtD
Metolazone—Dermatitis—Betamethasone—multiple sclerosis	0.000893	0.000893	CcSEcCtD
Metolazone—Fatigue—Methotrexate—multiple sclerosis	0.00089	0.00089	CcSEcCtD
Metolazone—Headache—Dexamethasone—multiple sclerosis	0.000889	0.000889	CcSEcCtD
Metolazone—Headache—Betamethasone—multiple sclerosis	0.000889	0.000889	CcSEcCtD
Metolazone—Asthenia—Prednisone—multiple sclerosis	0.000886	0.000886	CcSEcCtD
Metolazone—Pain—Methotrexate—multiple sclerosis	0.000883	0.000883	CcSEcCtD
Metolazone—Pruritus—Prednisone—multiple sclerosis	0.000874	0.000874	CcSEcCtD
Metolazone—Feeling abnormal—Methotrexate—multiple sclerosis	0.000851	0.000851	CcSEcCtD
Metolazone—Diarrhoea—Prednisone—multiple sclerosis	0.000845	0.000845	CcSEcCtD
Metolazone—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000844	0.000844	CcSEcCtD
Metolazone—Nausea—Betamethasone—multiple sclerosis	0.000842	0.000842	CcSEcCtD
Metolazone—Nausea—Dexamethasone—multiple sclerosis	0.000842	0.000842	CcSEcCtD
Metolazone—Urticaria—Methotrexate—multiple sclerosis	0.00082	0.00082	CcSEcCtD
Metolazone—Dizziness—Prednisone—multiple sclerosis	0.000817	0.000817	CcSEcCtD
Metolazone—Abdominal pain—Methotrexate—multiple sclerosis	0.000816	0.000816	CcSEcCtD
Metolazone—Vomiting—Prednisone—multiple sclerosis	0.000785	0.000785	CcSEcCtD
Metolazone—Rash—Prednisone—multiple sclerosis	0.000779	0.000779	CcSEcCtD
Metolazone—Dermatitis—Prednisone—multiple sclerosis	0.000778	0.000778	CcSEcCtD
Metolazone—Headache—Prednisone—multiple sclerosis	0.000774	0.000774	CcSEcCtD
Metolazone—Hypersensitivity—Methotrexate—multiple sclerosis	0.000761	0.000761	CcSEcCtD
Metolazone—Asthenia—Methotrexate—multiple sclerosis	0.000741	0.000741	CcSEcCtD
Metolazone—Nausea—Prednisone—multiple sclerosis	0.000734	0.000734	CcSEcCtD
Metolazone—Pruritus—Methotrexate—multiple sclerosis	0.00073	0.00073	CcSEcCtD
Metolazone—Diarrhoea—Methotrexate—multiple sclerosis	0.000706	0.000706	CcSEcCtD
Metolazone—Dizziness—Methotrexate—multiple sclerosis	0.000683	0.000683	CcSEcCtD
Metolazone—Vomiting—Methotrexate—multiple sclerosis	0.000656	0.000656	CcSEcCtD
Metolazone—Rash—Methotrexate—multiple sclerosis	0.000651	0.000651	CcSEcCtD
Metolazone—Dermatitis—Methotrexate—multiple sclerosis	0.00065	0.00065	CcSEcCtD
Metolazone—Headache—Methotrexate—multiple sclerosis	0.000647	0.000647	CcSEcCtD
Metolazone—Nausea—Methotrexate—multiple sclerosis	0.000613	0.000613	CcSEcCtD
